sfa 9:0

SFA 9:0, also known as nonanoic acid or pelargonic acid, is a medium-chain saturated fatty acid with a straight chain of nine carbon atoms and no double bonds. Chemical saturated fatty acids like nonanoic acid are classified by the length of the carbon chain and the absence of carbon-carbon double bonds. Nonanoic acid’s IUPAC designation is nonanoic acid, and it is also referred to as nonylic acid, pelargonic acid, or C9:0, where "C9" denotes nine carbons and ":0" indicates no double bonds. Medium-chain fatty acids (MCFAs) in general, including nonanoic acid (C9:0) and caprylic acid (C8:0), have distinct metabolic pathways compared to long-chain fatty acids because they are more water-soluble and are directly transported to the liver via the portal vein for rapid oxidation. While many nutritional guidelines and research focus on the broader categories of saturated, monounsaturated, and polyunsaturated fats, individual saturated fatty acids like nonanoic acid are not classified as essential nutrients because the human body synthesizes the necessary saturated fatty acids from carbohydrate and other substrates through de novo lipogenesis. As a result, authoritative bodies such as the U.S. National Institutes of Health (NIH) Office of Dietary Supplements and World Health Organization (WHO) do not provide Recommended Dietary Allowances (RDAs) specifically for nonanoic acid and do not consider it a nutrient that must be obtained in the diet. Nonanoic acid itself naturally occurs in small amounts in various dietary fats, mainly because saturated fatty acids are ubiquitous components of animal fats, dairy products, and certain plant oils. It also occurs in nature as esters in the oil of pelargonium and can be synthesized industrially as a chemical compound. In industrial contexts, nonanoic acid is used in manufacturing plasticizers, herbicides (such as ammonium nonanoate), and in flavor and fragrance applications. Its physical properties include being a clear to yellowish oily liquid with a relatively high boiling point and low solubility in water. The presence of nonanoic acid and other medium-chain fatty acids in food contributes to the overall fatty acid profile of triglycerides in dietary fats, and these profiles affect how fats are digested and metabolized. From a nutrition science perspective, the role of individual saturated fatty acids—including nonanoic acid—is typically considered within the context of total saturated fatty acid intake. Saturated fats have traditionally been associated with increased low-density lipoprotein (LDL) cholesterol, which is a risk factor for cardiovascular disease (CVD). For example, authoritative WHO guidelines suggest limiting saturated fat intake to less than 10% of total energy intake to reduce CVD risk. This reflects broad evidence that diets high in saturated fatty acids as a group can unfavorably influence blood lipid profiles. However, the evidence base also distinguishes among various chain lengths of saturated fatty acids, noting that short- and medium-chain fatty acids may have different metabolic effects compared with long-chain saturated fatty acids. Overall, understanding nonanoic acid’s chemistry, sources, and role in human metabolism provides insight into dietary fat quality and cardiovascular health considerations, even though the compound is not treated as a distinct essential nutrient.

While nonanoic acid (SFA 9:0) itself is not considered an essential nutrient with defined daily requirements, saturated fatty acids—including medium-chain fatty acids—play important roles in energy metabolism. Saturated fatty acids are components of triglycerides and phospholipids, which form structural elements of cell membranes and serve as a source of energy during periods of fasting and physical activity. In the context of energy metabolism, medium-chain fatty acids like nonanoic acid are more rapidly oxidized in the liver compared with long-chain fatty acids. This metabolic pathway results in faster conversion into acetyl-CoA and entry into the citric acid cycle to generate ATP. Saturated fatty acids have been studied extensively for their impact on cardiovascular health. Epidemiological and clinical evidence has historically linked high saturated fat intake with elevated LDL cholesterol levels and increased risk of atherosclerotic cardiovascular disease. As a result, public health guidelines from organizations such as the World Health Organization (WHO) recommend limiting saturated fatty acid intake to less than 10% of total energy intake to help reduce cardiovascular risk. These recommendations are based on the totality of available evidence assessing surrogate markers such as cholesterol levels and clinical endpoints including myocardial infarction and stroke. Although these guidelines apply to saturated fats as a group rather than individual chain lengths, they provide context for understanding the broader implications of dietary saturated fatty acids on health. Emerging research suggests that not all saturated fatty acids have identical metabolic effects. For example, saturated fatty acids of shorter chain length (such as those with fewer than 12 carbon atoms) and stearic acid (C18:0) tend to have a lesser effect on LDL cholesterol levels than other long-chain saturated fatty acids like palmitic (C16:0) and myristic (C14:0) acids. Medium-chain fatty acids, which include nonanoic acid, can be rapidly oxidized and may not contribute to adipose tissue accumulation to the same extent as longer chain saturated fats. Nonetheless, the primary focus of most clinical research and dietary recommendations remains on overall saturated fat intake rather than on individual fatty acids. In addition to metabolic roles, nonanoic acid has been investigated in vitro and in animal models for antimicrobial and immunomodulatory properties. Some studies indicate that nonanoic acid can reduce bacterial translocation and enhance antibacterial activity, potentially by upregulating host defense peptides in intestinal epithelial cells. Such findings suggest that nonanoic acid may exert localized effects in the gut microbiome or mucosal immunity under specific experimental conditions. However, these effects have not been clearly established in humans, and they do not support any formal health benefit claims in dietary or clinical practice. Another area of research concerns the interaction between dietary fatty acids and lipid metabolism pathways. Saturated fatty acids influence lipoprotein metabolism and inflammatory processes, whereas unsaturated fatty acids, particularly polyunsaturated fatty acids such as omega-3s, have been associated with anti-inflammatory effects and improved lipid profiles. Balancing saturated fat intake with healthy unsaturated fats from foods like oily fish, nuts, seeds, and vegetable oils is part of evidence-based dietary strategies to support cardiovascular health. In summary, nonanoic acid contributes to energy metabolism as part of the broader pool of saturated fatty acids, and while it has unique chemical properties and metabolic fates, its direct health benefits in humans remain understudied and are considered within the context of overall dietary fat quality.